Showing results (391-400 of 6,512) with videos related to

Sort By:
Pageof 652
Clinical Chemistry and Laboratory Medicine|August 11, 2021
Distribution of HOMA-IR in a population-based cohort and proposal for reference intervalsBassel Matli, Andreas Schulz, Thomas Koeck, et al.
Clinical Chemistry and Laboratory Medicine|August 11, 2021
Low free-T3 serum levels and prognosis of COVID-19: systematic review and meta-analysisMichael Llamas, Maria Luisa Garo, Luca Giovanella
Clinical Chemistry and Laboratory Medicine|February 23, 2023
Development of a candidate reference measurement procedure by ID-LC-MS/MS for total tau protein measurement in cerebrospinal fluid (CSF)Chiara Giangrande, Hélène Vaneeckhoutte, Amandine Boeuf, et al.
Clinical Chemistry and Laboratory Medicine|February 17, 2023
Pre-analytical considerations in the development of a prototype SARS-CoV-2 antigen ARCHITECT automated immunoassayPhilip M Hemken, Eitan Israeli, Russell Taylor, et al.
Clinical Chemistry and Laboratory Medicine|June 3, 1999
How to extinguish lymphocyte activation, immunotyrosine-based inhibition motif (ITIM)-bearing molecules a solution?M Blery, E Vivier
Clinical Chemistry and Laboratory Medicine|June 3, 1999
Apheresis of plasma compounds as a therapeutic principle in severe sepsis and multiorgan dysfunction syndromeB Stegmayr
Clinical Chemistry and Laboratory Medicine|June 3, 1999
Outcome prediction by traditional and new markers of inflammation in patients with sepsisM Oberhoffer, H Vogelsang, S Russwurm, et al.
Clinical Chemistry and Laboratory Medicine|June 3, 1999
Isolation of highly enriched human monocytes from ten ml samples of heparinised whole bloodG Wiegand, K Selleng, M Gründling, et al.
Clinical Chemistry and Laboratory Medicine|April 29, 1999
Allele-specific amplification for the diagnosis of autosomal recessive spinal muscular atrophyC Ravard-Goulvestre, C Boucly, B Mathieu, et al.
Clinical Chemistry and Laboratory Medicine|March 21, 2001
Evaluation of five commercial enzyme immunoassays for the detection of human cytomegalovirus-specific IgM antibodies in the absence of a commercially available gold standardB Genser, M Truschnig-Wilders, D Stünzner, et al.
Pageof 652